Wolfe Research Initiates Coverage On Olema Pharmaceuticals with Peer Perform Rating

Benzinga Newsdesk www.benzinga.com Positive 67.5%

Neg 0% Neu 0% Pos 67.5%

Wolfe Research analyst Kalpit Patel initiates coverage on Olema Pharmaceuticals (NASDAQ:OLMA) with a Peer Perform rating.